Co-host Llewellyn King interviews Dr. Andreas Kogelnik, MD, PhD, director of the recently formed
Open Medicine Institute in Mountain View, CA, which specializes in translational research for Chronic Fatigue Syndrome and other ‘difficult’ diseases. The OMI currently manages about 1,000 patients, Dr. Kogelnik says, and among other initiatives is running a pilot rituximab trial. He describes their plans for national trials of diagnostics & therapies involving a network of US ME/CFS specialists.
To view all MECFS Alert videos click HERE.